九强生物：α 1-抗胰蛋白酶测定试剂盒(免疫比浊法)获得医疗器械注册证

Core Viewpoint - The company has received a medical device registration certificate from the Beijing Drug Administration for a product that quantitatively measures the level of α1-antitrypsin (AAT) in human serum or plasma, which is a specialized reagent for Abbott's closed-channel instruments, enhancing the company's product line in the in vitro diagnostic biochemical segment [1] Group 1 - The new product will enrich the company's offerings in the in vitro diagnostic field, contributing to improved core competitiveness and market expansion capabilities [1] - The actual sales performance of the product will depend on future marketing efforts, and the company is currently unable to predict its impact on future performance [1]